| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10006894 | HBV | ENSG00000171766.17 | protein_coding | GATM | No | No | 2628 | P50440 |
| TVIS10006879 | HBV | ENSG00000171766.17 | protein_coding | GATM | No | No | 2628 | P50440 |
| TVIS10006888 | HBV | ENSG00000171766.17 | protein_coding | GATM | No | No | 2628 | P50440 |
| TVIS10016544 | HBV | ENSG00000171766.17 | protein_coding | GATM | No | No | 2628 | P50440 |
| TVIS10027378 | HBV | ENSG00000171766.17 | protein_coding | GATM | No | No | 2628 | P50440 |
| TVIS10059178 | HBV | ENSG00000171766.17 | protein_coding | GATM | No | No | 2628 | P50440 |
| TVIS20033309 | HPV | ENSG00000171766.17 | protein_coding | GATM | No | No | 2628 | P50440 |
| TVIS20034947 | HPV | ENSG00000171766.17 | protein_coding | GATM | No | No | 2628 | P50440 |
| TVIS44030758 | HTLV-1 | ENSG00000171766.17 | protein_coding | GATM | No | No | 2628 | P50440 |
| TVIS44027190 | HTLV-1 | ENSG00000171766.17 | protein_coding | GATM | No | No | 2628 | P50440 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GATM |
|---|---|
| DrugBank ID | DB00145 |
| Drug Name | Glycine |
| Target ID | BE0000347 |
| UniProt ID | P50440 |
| Regulation Type | substrate |
| PubMed IDs | 17486546 |
| Citations | Wang L, Zhang Y, Shao M, Zhang H: Spatiotemporal expression of the creatine metabolism related genes agat, gamt and ct1 during zebrafish embryogenesis. Int J Dev Biol. 2007;51(3):247-53. |
| Groups | Approved; Nutraceutical; Vet_approved |
| Direct Classification | Alpha amino acids |
| SMILES | NCC(O)=O |
| Pathways | gamma-Glutamyltranspeptidase Deficiency; Lesch-Nyhan Syndrome (LNS); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Molybdenum Cofactor Deficiency; AICA-Ribosiduria; Purine Nucleoside Phosphorylase Deficiency; gamma-Glutamyltransferase Deficiency; Hyperprolinemia Type II; Glutamate Metabolism; Adenine Phosphoribosyltransferase Deficiency (APRT); Mercaptopurine Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); L-Arginine:Glycine Amidinotransferase Deficiency; Hyperinsulinism-Hyperammonemia Syndrome; Congenital Bile Acid Synthesis Defect Type II; Porphyrin Metabolism; Prolidase Deficiency (PD); Glycine and Serine Metabolism; Carnitine Synthesis; Adenosine Deaminase Deficiency; Methionine Metabolism; Bile Acid Biosynthesis; Hyperprolinemia Type I; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; 27-Hydroxylase Deficiency; Sarcosine Oncometabolite Pathway; Purine Metabolism; Gout or Kelley-Seegmiller Syndrome; Ammonia Recycling |
| PharmGKB | PA449789 |
| ChEMBL | CHEMBL773 |
